CompletedNot Applicable

The COVID-19 Pandemic and Exercise Study

Canada334 participantsStarted 2020-06-01

Plain-language summary

The COPE Trial is a randomized controlled trial that will provide currently isolated yet generally physically healthy 18-64 year old adults who are pre-retirement with the opportunity to receive a free 3-month subscription to either a yoga or moderate-to-high intensity aerobic exercise app or be randomized to a waitlist control group. Study outcomes include measures of psychological wellbeing and physical health.

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Between 18-64 * Still working or pre-retirement * Currently completing less than 150 minutes of moderate activity per week, and/or 75 minutes if vigorous activity per week * has at-home internet/computer access * English speaking Exclusion Criteria: * Retired * Meeting activity guidelines (i.e. at least 150 min of moderate or 75 min of vigorous intensity exercise per week * Major health conditions that limit ability to exercise * Hospitalization in the last 3 months

What they're measuring

Changes in depressive symptomology over the course of the exercise intervention

Timeframe: Tracked weekly for 7 weeks (baseline, followed by 6 weeks of exercise intervention) and then a final CES-D survey at week 12

Trial details

NCT IDNCT04400279

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-11-28

View on ClinicalTrials.gov More Depressive Symptomatology trials